RE:RE:RE:RE:Results of rights offering? where is it?Don't forget Chronic Cough. After the Phase 2 trial in Australia, some of the patients in the trial asked if they could continue to be treated with Ifenprodil.
Presumably, these people had previously been treated with the approved standard of care drug, which I think was Merck's.
So, Big Pharma knows that Algernon owns rights on a potentially profitable drug now in Stage 2 trials